Petgo

Petgo EBITDA per Employee

The EBITDA per Employee of Petgo (7140.T) as of Oct 28, 2026 is -3.93 M JPY. In the previous year, EBITDA per Employee was 4.39 M JPY — a change of -189.33% (lower).

EBITDA per Employee

-3.93 MJPY

YoY

-189.33%

Last updated:

EBITDA per Employee of Petgo is 2026 -3.93 M JPY. EBITDA per Employee of Petgo was 2025 4.39 M JPY. It decreases by -189.33% lower compared to the previous year.

The Petgo EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2020
-76,653.85 JPY
Jan 1, 2021
1.92 M JPY
Jan 1, 2022
3.18 M JPY
Jan 1, 2023
4.54 M JPY
Jan 1, 2024
4.75 M JPY
Jan 1, 2025
4.39 M JPY
Jan 1, 2026
-3.93 M JPY
The Petgo EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-3.93 MJPY-189.33%
4.39 MJPY-7.52%
4.75 MJPY+4.62%
4.54 MJPY+42.99%
3.18 MJPY+65.35%
1.92 MJPY-2,605.75%
-76,653.85JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Petgo Stock analysis

What does Petgo do? Petgo Corp. generates revenue by selling veterinary drugs, dietary foods, and supplements exclusively available at animal hospitals through its e-commerce platform petgo and other online malls. The company focuses on products such as flea and tick repellents, eye drops, dermatitis treatments, external otitis medicine, gastrointestinal medicine, and general nutrition foods for dogs and cats. Its primary customers are pet owners seeking specialized healthcare solutions for their pets, particularly those requiring prescription-only items typically sold at animal hospitals. The firm serves the pet healthcare segment within the e-commerce market, emphasizing convenience and access to restricted veterinary products. The business model centers on e-commerce sales of pet healthcare products, leveraging both its own online site petgo and partnerships with other online malls. Revenue streams come from the sale of veterinary drugs, dietary supplements, and care products, with a strong emphasis on items that are only available through animal hospitals. The company targets pet owners who prioritize professional-grade healthcare for their pets, avoiding generic pet product markets to maintain a niche focus. This approach allows Petgo Corp. to cater to a specific segment of the pet care industry that requires specialized medical products. Petgo Corp. operates within the pet healthcare sector, specifically focusing on e-commerce sales of prescription-only items like flea and tick repellents and gastrointestinal medicine. The company's product range includes veterinary drugs, dietary foods, and supplements, all sold through its online platform and other online malls. Its target market consists of pet owners who need access to animal hospital-exclusive products without visiting clinics, making it a convenient solution for ongoing pet healthcare needs. The firm's revenue is derived from direct sales of these specialized products, ensuring a steady income stream from a dedicated customer base. Petgo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Petgo stock

EBITDA per Employee of Petgo is -3.93 M JPY in 2026.

EBITDA per Employee of Petgo changed from 4.39 M JPY to -3.93 M JPY, representing a -189.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Petgo since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Petgo historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Petgo

All Key Metrics — Petgo